Literature DB >> 23032601

Gene therapy through autologous transplantation of gene-modified hematopoietic stem cells.

Donald B Kohn1, Sung-Yun Pai, Michel Sadelain.   

Abstract

Mesh:

Year:  2012        PMID: 23032601     DOI: 10.1016/j.bbmt.2012.09.021

Source DB:  PubMed          Journal:  Biol Blood Marrow Transplant        ISSN: 1083-8791            Impact factor:   5.742


× No keyword cloud information.
  15 in total

1.  Gene-modified hematopoietic stem cells for cancer immunotherapy.

Authors:  Sarah Larson; Satiro N De Oliveira
Journal:  Hum Vaccin Immunother       Date:  2014-01-09       Impact factor: 3.452

Review 2.  Development of gene therapy for blood disorders: an update.

Authors:  Arthur W Nienhuis
Journal:  Blood       Date:  2013-07-10       Impact factor: 22.113

3.  Envelope, please. And the award goes to….

Authors:  Donald B Kohn; Roger P Hollis
Journal:  Blood       Date:  2014-08-21       Impact factor: 22.113

4.  The special case of gene therapy pricing.

Authors:  Troyen A Brennan; James M Wilson
Journal:  Nat Biotechnol       Date:  2014-09       Impact factor: 54.908

5.  Enrichment of human hematopoietic stem/progenitor cells facilitates transduction for stem cell gene therapy.

Authors:  Kismet Baldwin; Fabrizia Urbinati; Zulema Romero; Beatriz Campo-Fernandez; Michael L Kaufman; Aaron R Cooper; Katelyn Masiuk; Roger P Hollis; Donald B Kohn
Journal:  Stem Cells       Date:  2015-05       Impact factor: 6.277

6.  Next generation research and therapy in red blood cell diseases.

Authors:  Roberta Russo; Immacolata Andolfo; Achille Iolascon
Journal:  Haematologica       Date:  2016-05       Impact factor: 9.941

Review 7.  Anemia: progress in molecular mechanisms and therapies.

Authors:  Vijay G Sankaran; Mitchell J Weiss
Journal:  Nat Med       Date:  2015-03       Impact factor: 53.440

Review 8.  Hematopoietic stem cells for cancer immunotherapy.

Authors:  Eric Gschweng; Satiro De Oliveira; Donald B Kohn
Journal:  Immunol Rev       Date:  2014-01       Impact factor: 12.988

9.  Preliminary evaluation of a highly automated instrument for the selection of CD34+ cells from mobilized peripheral blood stem cell concentrates.

Authors:  David F Stroncek; Minh Tran; Sue Ellen Frodigh; Virginia David-Ocampo; Jiaqiang Ren; Andre Larochelle; Virginia Sheikh; Irini Sereti; Jeffery L Miller; Kevin Longin; Marianna Sabatino
Journal:  Transfusion       Date:  2015-10-27       Impact factor: 3.157

10.  Primary Immune Deficiency Treatment Consortium (PIDTC) report.

Authors:  Linda M Griffith; Morton J Cowan; Luigi D Notarangelo; Donald B Kohn; Jennifer M Puck; Sung-Yun Pai; Barbara Ballard; Sarah C Bauer; Jack J H Bleesing; Marcia Boyle; Amy Brower; Rebecca H Buckley; Mirjam van der Burg; Lauri M Burroughs; Fabio Candotti; Andrew J Cant; Talal Chatila; Charlotte Cunningham-Rundles; Mary C Dinauer; Christopher C Dvorak; Alexandra H Filipovich; Thomas A Fleisher; Hubert Bobby Gaspar; Tayfun Gungor; Elie Haddad; Emily Hovermale; Faith Huang; Alan Hurley; Mary Hurley; Sumathi Iyengar; Elizabeth M Kang; Brent R Logan; Janel R Long-Boyle; Harry L Malech; Sean A McGhee; Fred Modell; Vicki Modell; Hans D Ochs; Richard J O'Reilly; Robertson Parkman; David J Rawlings; John M Routes; William T Shearer; Trudy N Small; Heather Smith; Kathleen E Sullivan; Paul Szabolcs; Adrian Thrasher; Troy R Torgerson; Paul Veys; Kenneth Weinberg; Juan Carlos Zuniga-Pflucker
Journal:  J Allergy Clin Immunol       Date:  2013-10-15       Impact factor: 10.793

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.